MK-6050: Study in Healthy Volunteers

We are investigating the effects of MK-6050 in healthy individuals. This research aims to gather important safety information about the medication.

3-6 monthsSafety phase (I)AllergologyDermatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
SGS Belgium
SGS Clinical Pharmacology Unit
Wilrijk, Belgium
Sponsor: Merck Sharp & Dohme LLC
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.